baricitinib January 19, 2018 baricitinib Trade Name Olumiant Orphan Indication Pediatric systemic lupus erythematosus USA Market Approval USA USA Designation Date 2017-11-02 00:00:00 Sponsor Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285
